ICM
WBA

Invenomic Capital Management’s Walgreens Boots Alliance WBA Stock Holding History

Invenomic Capital Management’s Portfolio WBA Stock Details WBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-237,663
Closed -$6.21M – 198
2023
Q4 		$6.21M Sell
237,663
-216,482
-48% -$4.84M 0.28% 93
2023
Q3 		$10.1M Buy
454,145
+334,943
+281% +$8.91M 0.42% 67
2023
Q2 		$3.4M Sell
119,202
-11,570
-9% -$377K 0.17% 100
2023
Q1 		$4.52M Buy
+130,772
New +$4.64M 0.26% 96

Other funds holding WBA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invenomic Capital Management's WBA Position: Q1 2024 in Review

Invenomic Capital Management sold out of Walgreens Boots Alliance (WBA) in Q1 2024, closing a stake of 237,663 shares — an estimated $6.21M sold.

Invenomic Capital Management first reported a position in WBA in Q1 2023 and held it in 4 quarters. The position peaked at $10.1M in Q3 2023. 995 funds tracked by Wall St. Rank hold WBA as of Q1 2024.

  • Invenomic Capital Management reported no remaining Walgreens Boots Alliance position as of Q1 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 237,663 Walgreens Boots Alliance shares in Q1 2024, an estimated $6.21M.
  • Invenomic Capital Management first reported a position in Walgreens Boots Alliance in Q1 2023 and held it in 4 quarters.
  • Invenomic Capital Management's Walgreens Boots Alliance position peaked at $10.1M in Q3 2023.
  • 995 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.